Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells.
Lai Y, Weng J, Wei X, Qin L, Lai P, Zhao R, Jiang Z, Li B, Lin S, Wang S, Wu Q, Tang Z, Liu P, Pei D, Yao Y, Du X, Li P.
Lai Y, et al. Among authors: lin s.
Leukemia. 2018 Mar;32(3):801-808. doi: 10.1038/leu.2017.249. Epub 2017 Aug 3.
Leukemia. 2018.
PMID: 28841215